PHE report on HIV and STIs during COVID-19
22 January 2021. Related: HIV prevention and transmission.
HIV prevention and transmission
Worryingly low HIV knowledge among health workers at London hospital: 80% unaware of U=U, 36% worried about their risk from patients
9 December 2020. Related: Conference reports, HIV prevention and transmission.
Innovation benefits of cabotegravir LA injections for HIV PrEP will enable a closer FDA review
9 December 2020. Related: HIV prevention and transmission.
Once-monthly oral pill as PrEP against HIV: islatravir study to start in 2021
9 December 2020. Related: HIV prevention and transmission.
HIV in the UK: diagnoses continued to fall during 2019 but 42% are still late
11 November 2020. Related: HIV prevention and transmission.
Two-monthly cabotegravir injections prevent HIV infection in African women: HPTN 084 study recommends early unblinding
11 November 2020. Related: HIV prevention and transmission.
FTC exposure higher in young transgender men than cisgender controls
14 October 2020. Related: Conference reports, PK and drug interactions, HIV prevention and transmission.
Levels of long-acting anti-HIV bNAb high in infants after 1 or 2 doses – but not high enough
14 October 2020. Related: Conference reports, Paediatric care, PK and drug interactions, HIV prevention and transmission.
BASHH 2020 PEP guidelines: online for comment
14 October 2020. Related: Guidelines, HIV prevention and transmission.
EMA supports use of dapivirine vaginal ring to prevent HIV in high-incidence countries
28 August 2020. Related: HIV prevention and transmission.
Long-acting cabotegravir injections are effective as HIV PrEP in gay men and transgender women: results from HPTN 083
22 July 2020. Related: Conference reports, HIV prevention and transmission.
UK government cuts HIV PrEP budget in England by a third
22 July 2020. Related: HIV prevention and transmission.
Cabotegravir long-acting injections prevent HIV as PrEP
1 June 2020. Related: HIV prevention and transmission.
PrEP recommended by NHS England (at last)
17 April 2020. Related: HIV prevention and transmission.
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
27 March 2020. Related: HIV prevention and transmission, COVID-19: transmission & prevention, COVID-19.
Monthly islatravir for PEP and PrEP: 12 pills a year could cover unmet need for HIV prevention in billions of people globally
12 March 2020. Related: Conference reports, HIV prevention and transmission.
No HIV transmission among Swiss infants born to mothers with undetectable viral load and who did not receive neonatal PEP
24 February 2020. Related: Conference reports, HIV prevention and transmission.
HIV in the UK – 2019 reports and data
24 February 2020. Related: HIV prevention and transmission, On the web.
Large phase 3 HIV vaccine study in south Africa is stopped early due to lack of efficacy
21 February 2020. Related: HIV prevention and transmission, Vaccines and microbicides.
i-Base guide to HIV testing and sexual transmission (January 2020)
29 January 2020. Related: Supplements, HIV prevention and transmission.
UK Guide to PrEP – November 2019
13 December 2019. Related: Supplements, HIV prevention and transmission.
US government claims patent infringement by Gilead Sciences over use of F/TAF and FTC/TDF as PrEP
15 November 2019. Related: Treatment access, HIV prevention and transmission.
PrEP linked to lower HIV incidence in US, independent of TasP
18 October 2019. Related: Conference reports, HIV prevention and transmission.
US approves F/TAF for PrEP (Descovy): indication excludes risk from receptive vaginal sex
18 October 2019. Related: HIV prevention and transmission.
WHO update PrEP guidelines to include event-based dosing
30 September 2019. Related: Guidelines, HIV prevention and transmission.
UK issue joint guidelines on HIV discrimination in tattoo and beauty salons
30 September 2019. Related: Guidelines, HIV prevention and transmission.
PK advantages of TAF/FTC over TDF/FTC for HIV PrEP might compensate for low adherence: sub-analysis of DISCOVER study
23 August 2019. Related: Conference reports, HIV prevention and transmission.
Islatravir (MK-8591) implant sustains HIV PrEP protection for more than one year
24 July 2019. Related: Conference reports, HIV prevention and transmission.
Two pints of lager and a packet of PrEP please: London price for HIV PrEP drops to £17.50
19 June 2019. Related: Treatment access, HIV prevention and transmission.
Activists challenge block to generic PrEP and current US price of TDF/FTC
19 June 2019. Related: Treatment access, HIV prevention and transmission.
Fifty new HIV diagnoses at Dean Street linked to caps on IMPACT study
20 May 2019. Related: Conference reports, HIV prevention and transmission.
PARTNER 2 study published in the Lancet: global news coverage that ART stops HIV transmission
3 May 2019. Related: HIV prevention and transmission.
BHIVA preconference: U=U and HIV and immigration detention
30 April 2019. Related: Conference reports, Treatment access, HIV prevention and transmission.
bNAb research at CROI 2019: vaccine, prevention, treatment and cure…
30 April 2019. Related: Conference reports, Treatment strategies, HIV prevention and transmission, Cure-related research.
New option for PrEP – TAF/FTC is non-inferior to TDF/FTC: results of phase 3 DISCOVER study
12 March 2019. Related: Conference reports, HIV prevention and transmission.
Arabic translation of U=U factsheet
20 February 2019. Related: HIV prevention and transmission.
NHS England doubles places on IMPACT PrEP study to 26,000
21 January 2019. Related: HIV prevention and transmission.
US CDC updates HIV rates in transgender people
21 January 2019. Related: HIV prevention and transmission.
UK annual HIV surveillance data published – full reports
21 January 2019. Related: HIV prevention and transmission.
Michigan State updates HIV disclosure laws to reflect impact of effective ART
21 January 2019. Related: HIV prevention and transmission, Other news.
3rd HIV Research for Prevention Conference (R4P2018) – second reports
12 December 2018. Related: Conference reports, HIV prevention and transmission.
3D printing technology has potential to individualise production of vaginal rings
12 December 2018. Related: Conference reports, HIV prevention and transmission.
3rd HIV Research for Prevention Conference (R4P2018)
13 November 2018. Related: Conference reports, HIV prevention and transmission.
How to evaluate PrEP and vaccines: urgency for next generation compounds
13 November 2018. Related: Conference reports, HIV prevention and transmission, Cure-related research, Research studies.
3D imaging show HIV infection might establish within hours
13 November 2018. Related: Conference reports, HIV prevention and transmission.
bNAbs for HIV prevention: extended-release VRC01, AMP study, 10E8 safety signal and pan-clade challenges
13 November 2018. Related: Conference reports, PK and drug interactions, HIV prevention and transmission.
New UK PrEP guidelines 2018
19 October 2018. Related: Conference reports, HIV prevention and transmission.
UK PrEP guidelines now online (2018)
19 October 2018. Related: Guidelines, HIV prevention and transmission.
HIV diagnoses in UK drop for third year: among all ages, risk groups, and ethnicities and across most UK regions
19 September 2018. Related: Special reports, HIV prevention and transmission.
English court finds in favour of access to generic TDF/FTC
19 September 2018. Related: Antiretrovirals, HIV prevention and transmission, Other news.
High rates of anal HPV infection in gay men using PrEP in IPERGAY: the role of vaccination
24 August 2018. Related: Conference reports, Cancer and HIV, HIV prevention and transmission.
Janssen HIV vaccine: update from APPROACH and largescale efficacy study
24 August 2018. Related: Conference reports, HIV prevention and transmission, Cure-related research.
Resolving a diagnosis for people with persistently indeterminate HIV test results
24 August 2018. Related: Conference reports, Diagnostics, HIV prevention and transmission.
Zero HIV transmissions in PARTNER 2 study after gay couples had sex 77,000 times without condoms – an undetectable viral load stops HIV
3 August 2018. Related: Conference reports, HIV prevention and transmission.
Using PrEP with feminising hormone therapy supports daily PrEP dosing for transwomen
3 August 2018. Related: Conference reports, PK and drug interactions, HIV prevention and transmission.
Daily and on-demand PrEP both prevent HIV in Prévenir study: high adherence by gay Parisians
3 August 2018. Related: Conference reports, HIV prevention and transmission.
Why U=U does not apply to breastfeeding
11 July 2018. Related: Pregnancy, HIV prevention and transmission.
New FDA guidance for developing PrEP drugs
29 June 2018. Related: HIV prevention and transmission.
UK PrEP IMPACT trial announces 3000 new places for gay men but low uptake by women, African and transgender people
29 June 2018. Related: HIV prevention and transmission.
Broad PrEP access in Australia reduces HIV infections even with reduced condom use by people not on PrEP
8 June 2018. Related: HIV prevention and transmission.
Webcasts on PrEP and women
8 June 2018. Related: HIV prevention and transmission, On the web.
Low PEP and PrEP awareness among trans people in London and their partners
21 May 2018. Related: Conference reports, HIV prevention and transmission.
Low awareness of PrEP in BME communities in Leeds but high interest in use
21 May 2018. Related: Conference reports, HIV prevention and transmission.
Zero or negligible risks of HIV, HBV or HCV transmission by biting or spitting
21 May 2018. Related: Conference reports, HIV prevention and transmission.
Almost 1 in 8 people with symptoms turned away from sexual health clinics in SE London: 40% are under 25 and 6% under 18 years old
1 May 2018. Related: Conference reports, Treatment access, Women's health, Pregnancy, HIV prevention and transmission.